|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization of long-term assets | ||||
| Noncash lease expense | ||||
| Amortization of debt discount | ||||
| Change in fair value of contingent consideration liability - related parties | ||||
| Change in fair value of securities carried at fair value | ||||
| In-process research and development expense | ||||
| Stock-based compensation expense | ||||
| Change in fair value of assets and liabilities, net | ||||
| Noncash change in the fair value of assets and liabilities, net | ||||
| Unrealized loss on other investments held at fair value | ||||
| Gain on dilution of equity method investment | ||||
| Loss on conversion of convertible notes | ||||
| Gain on consolidation of a variable interest entity | ||||
| Loss on sale of investment held at fair value | ||||
| Gain on dissolution of a variable interest entity | ||||
| Gain on settlement of pre-existing contract | ||||
| Impairment of intangible assets | ||||
| Gain on deconsolidation of a variable interest entity, net | ||||
| Impairment of short term note receivable | ||||
| Provision for deferred income taxes | ||||
| Change in fair value of derivative liability | ||||
| Impairment of other investments | ||||
| Unrealized foreign exchange loss, net | ||||
| Losses from investments in equity method investees, net of tax | ||||
| Other | ||||
| Other income (expense), net | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other current assets | ||||
| Other assets | ||||
| Accounts payable | ||||
| Accrued liabilities and other liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities | ||||
| Proceeds from sale and maturities of securities carried at fair value | ||||
| Funds committed for investments | ||||
| Proceeds from sale of other investment held at fair value | ||||
| Cash received in acquisition of IntelGenx Corp. | ||||
| Cash paid for asset acquisitions, net | ||||
| Cash paid for equity method investments | ||||
| Cash paid for securities carried at fair value | ||||
| Cash paid for investments | ||||
| Cash paid for short-term notes receivable - related party | ||||
| Cash paid for short-term convertible notes receivable and warrant - related party | ||||
| Cash paid for intangible asset | ||||
| Cash paid for long-term notes receivable - related parties, net | ||||
| Cash paid for convertible notes receivable - related party | ||||
| Cash paid for other investments held at fair value | ||||
| Proceeds from sale of other investment | ||||
| Cash paid for capitalized internal-use software development costs | ||||
| Cash paid out in variable interest entity deconsolidation | ||||
| Cash paid for property and equipment | ||||
| Net cash provided by (used in) investing activities | ||||
| Cash flows from financing activities | ||||
| Proceeds from issuance of common stock | ||||
| Cash paid for common stock issuance costs | ||||
| Proceeds from issuance of share option awards | ||||
| Proceeds from secured borrowing liability | ||||
| Proceeds from issuance of subsidiary preferred shares | ||||
| Proceeds from debt financing | ||||
| Proceeds from issuance of shares upon exercise of stock options | ||||
| Proceeds from conversion of convertible notes to common stock | ||||
| Cash paid for acquisition of noncontrolling interest | ||||
| Financing costs paid | ||||
| Proceeds from issuance of convertible promissory notes | ||||
| Net cash provided by (used in) financing activities | ||||
| Effect of foreign exchange rate changes on cash | ||||
| Net decrease in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash - beginning of the period | ||||
| Cash, cash equivalents and restricted cash - end of the period | ||||
| Supplemental disclosures: | ||||
| Cash paid for interest | ||||
| Cash paid for taxes | ||||
| Supplemental disclosures of noncash investing and financing information: | ||||
| Discharge of notes receivable | ||||
| Noncash exchange of convertible promissory note modification | ||||
| Noncash consideration for acquisition of noncontrolling interest, net | ||||
| Noncash receipt of call option | ||||
| Noncash deferred credit | ||||
| Right of use asset obtained in exchange for operating lease liabilities | ||||
| Issuance of subsidiary shares in connection with a stock purchase agreement | ||||
| Share subscription receivable | ||||
| Fair value of noncontrolling interests issued in connection with consolidation of a VIE | ||||
| Fair value of redeemable noncontrolling interests issued in connection with consolidation of a VIE | ||||
| Fair value of noncontrolling interests issued in connection with asset acquisitions | ||||
| Issuance of derivative instrument related to convertible promissory notes | ||||
| Exercise of Hurdle Share Option Plan award | ||||
| Issuance Of Subsidiary Shares In Connection With The Conversion Of Convertible Notes | ||||
| Noncash consideration for variable interest deconsolidation | ||||
Loading...